| Date Filed | Type | Description |
| 10/02/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 08/22/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 08/22/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 08/18/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 08/16/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 08/14/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/02/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 08/02/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 08/02/2023 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 07/28/2023 |
SC 13E3/A
| Form SC 13E3/A - Going private transaction by certain issuers: [Amend] |
| 07/28/2023 |
PRER14A
| Form PRER14A - Preliminary Proxy Soliciting materials: |
| 07/11/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 07/11/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 06/30/2023 |
SC 13E3
| Form SC 13E3 - Going private transaction by certain issuers: |
| 06/30/2023 |
PREM14A
| Form PREM14A - Preliminary proxy statements relating to merger or acquisition: |
| 06/07/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 06/07/2023 |
8-K
| Acquisition/merger/asset purchase announced|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Agreement and Plan of Merger, by and among the Company, Resistance Acquisition, Inc. and Resistance Merger Sub, Inc",
"Form of Contingent Value Rights Agreement to be entered into between Resistance Acquisition, Inc. and a Rights Agent",
"Form of Voting Agreement to be entered into between Parent and the Management Stockholders",
"Paratek Pharmaceuticals to be Acquired by Gurnet Point Capital and Novo Holdings" |
|
| 06/06/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 06/06/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 06/06/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 06/06/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/18/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/09/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/27/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
| 03/20/2023 |
SC 13G/A
| HIRSCHMAN ORIN reports a 4.9% stake in Paratek Pharmaceuticals, Inc. |
| 03/17/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/16/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/14/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Interactive Data |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/20/2023 |
SC 13G/A
| NexPoint Real Estate Opportunities, LLC reports a 7% stake in Paratek Pharmaceuticals, Inc. |
| 11/03/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 08/03/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
|